NCT04582604 2020-10-20
Ruxolitinib and Decitabine for High Risk Hematological Malignancies
Chinese PLA General Hospital
Phase 1/2 Unknown
Clinical Trials
4 trialsNCT03558607 2020-03-19
The Role of Ruxolitinib in Secondary Acute Myelogenous Leukemia Evolving From Myeloproliferative Neoplasm
Seoul National University Hospital
Phase 1/2 Unknown
NCT03613428 2018-08-03
Ruxolitinib Plus LVP in Patients With R/R ETP-ALL
Sichuan University
Phase 1/2 Unknown
NCT02912754 2017-03-13
Ruxolitinib Combined With Ibrutinib in Chronic Lymphocytic Leukemia Patients
Sunnybrook Health Sciences Centre
Phase 1/2 Unknown